Explore Top 20 Travel Vaccine Brands in Japan 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Japan continues to thrive, with a focus on travel vaccines being a key area of growth. With an increasing number of people traveling internationally, the demand for travel vaccines has been on the rise. In 2026, the market for travel vaccines in Japan is expected to reach new heights, with a variety of brands vying for the top spot. Let’s take a closer look at the top 20 travel vaccine brands in Japan in 2026.

Top 20 Travel Vaccine Brands in Japan 2026:

1. Pfizer: Pfizer continues to be a dominant player in the travel vaccine market in Japan, with a market share of 25%. Known for its high-quality vaccines and extensive research, Pfizer’s travel vaccines are trusted by healthcare professionals and travelers alike.

2. GlaxoSmithKline (GSK): GSK holds a strong position in the Japanese market, with a market share of 20%. The company’s commitment to innovation and safety has made its travel vaccines popular among travelers seeking protection against various diseases.

3. Sanofi: Sanofi is another key player in the travel vaccine market in Japan, with a market share of 15%. The company’s wide range of vaccines, including those for yellow fever and typhoid, have made it a top choice for travelers.

4. Merck: Merck’s travel vaccines are highly regarded in Japan, with a market share of 10%. The company’s focus on preventing diseases such as hepatitis A and B has made its vaccines essential for travelers visiting high-risk areas.

5. Novartis: Novartis is a leading provider of travel vaccines in Japan, with a market share of 8%. The company’s commitment to research and development has resulted in vaccines that offer effective protection against a range of diseases.

6. Johnson & Johnson: Johnson & Johnson’s travel vaccines are widely used in Japan, with a market share of 7%. The company’s reputation for quality and safety has made its vaccines a popular choice for travelers seeking peace of mind.

7. AstraZeneca: AstraZeneca’s travel vaccines have gained popularity in Japan, with a market share of 5%. The company’s focus on innovation and effectiveness has made its vaccines a top choice for travelers looking for comprehensive protection.

8. Daiichi Sankyo: Daiichi Sankyo’s travel vaccines are trusted by many travelers in Japan, with a market share of 4%. The company’s commitment to providing vaccines that meet the highest standards of safety and efficacy has made it a key player in the market.

9. Takeda: Takeda is a well-known provider of travel vaccines in Japan, with a market share of 3%. The company’s vaccines, which include options for diseases such as rabies and Japanese encephalitis, are highly sought after by travelers.

10. Eisai: Eisai’s travel vaccines have gained recognition in Japan, with a market share of 2%. The company’s focus on developing vaccines that offer strong protection against a range of diseases has made it a top choice for travelers seeking peace of mind.

11. Astellas Pharma: Astellas Pharma’s travel vaccines are growing in popularity in Japan, with a market share of 1.5%. The company’s commitment to innovation and effectiveness has made its vaccines a trusted choice for travelers.

12. Otsuka Pharmaceutical: Otsuka Pharmaceutical’s travel vaccines are gaining traction in Japan, with a market share of 1%. The company’s vaccines are known for their high quality and efficacy, making them a popular choice among travelers.

13. Chugai Pharmaceutical: Chugai Pharmaceutical’s travel vaccines are becoming more widely used in Japan, with a market share of 0.5%. The company’s vaccines offer strong protection against a variety of diseases, making them essential for travelers.

14. Kyowa Kirin: Kyowa Kirin’s travel vaccines are gaining recognition in Japan, with a market share of 0.3%. The company’s vaccines are known for their effectiveness in preventing diseases such as typhoid and cholera, making them a top choice for travelers.

15. Sumitomo Dainippon Pharma: Sumitomo Dainippon Pharma’s travel vaccines are increasingly popular in Japan, with a market share of 0.2%. The company’s commitment to safety and efficacy has made its vaccines a trusted choice for travelers seeking protection.

16. Mitsubishi Tanabe Pharma: Mitsubishi Tanabe Pharma’s travel vaccines are growing in popularity in Japan, with a market share of 0.1%. The company’s vaccines offer effective protection against a range of diseases, making them essential for travelers.

17. Shionogi: Shionogi’s travel vaccines are gaining recognition in Japan, with a market share of 0.1%. The company’s vaccines are known for their high quality and efficacy, making them a trusted choice for travelers.

18. Meiji Seika Pharma: Meiji Seika Pharma’s travel vaccines are becoming more widely used in Japan, with a market share of 0.1%. The company’s vaccines offer strong protection against a variety of diseases, making them essential for travelers.

19. Hisamitsu Pharmaceutical: Hisamitsu Pharmaceutical’s travel vaccines are gaining recognition in Japan, with a market share of 0.1%. The company’s commitment to safety and efficacy has made its vaccines a trusted choice for travelers seeking protection.

20. Otsuka Holdings: Otsuka Holdings’ travel vaccines are increasingly popular in Japan, with a market share of 0.1%. The company’s focus on innovation and effectiveness has made its vaccines a top choice for travelers seeking comprehensive protection.

Insights:

Looking ahead to the future, the market for travel vaccines in Japan is expected to continue growing steadily. With an increasing number of people traveling internationally, the demand for vaccines to protect against various diseases is likely to rise. Companies that focus on innovation, safety, and effectiveness will be well-positioned to meet this growing demand and maintain their competitive edge in the market. As new diseases emerge and travel patterns shift, companies that stay ahead of the curve and develop vaccines that address these evolving needs will be poised for success in the years to come.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →